Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 31.05
+0.15 (0.49%)
At close: Dec 5, 2025
Medigen Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 891.78 | 1,388 | 2,223 | 2,041 | 2,145 | 2,207 | Upgrade
|
| Short-Term Investments | 1,480 | 1,200 | 2,364 | 3,040 | 800 | - | Upgrade
|
| Trading Asset Securities | 0.3 | 0.59 | 0.49 | 54.23 | 53.6 | 54.2 | Upgrade
|
| Cash & Short-Term Investments | 2,372 | 2,588 | 4,588 | 5,135 | 2,998 | 2,261 | Upgrade
|
| Cash Growth | -3.96% | -43.58% | -10.67% | 71.28% | 32.62% | 146.78% | Upgrade
|
| Accounts Receivable | 378.52 | 286.07 | 328.89 | 398.31 | 800.22 | 151.21 | Upgrade
|
| Other Receivables | 76.13 | 87.61 | 124.72 | 66.37 | 35.46 | 130.51 | Upgrade
|
| Receivables | 454.65 | 373.67 | 453.61 | 464.69 | 835.68 | 281.72 | Upgrade
|
| Inventory | 683.36 | 645.06 | 546.91 | 692.62 | 752.87 | 323.29 | Upgrade
|
| Prepaid Expenses | 20.77 | 22.76 | 33.61 | 382.35 | 99.59 | - | Upgrade
|
| Other Current Assets | 22.7 | 31.36 | 86.4 | 57.93 | 231.96 | 155.9 | Upgrade
|
| Total Current Assets | 3,554 | 3,661 | 5,708 | 6,733 | 4,918 | 3,022 | Upgrade
|
| Property, Plant & Equipment | 1,918 | 1,981 | 2,043 | 2,198 | 2,189 | 2,166 | Upgrade
|
| Long-Term Investments | 490.67 | 640.35 | 292.87 | 307.33 | 363.71 | 156.49 | Upgrade
|
| Goodwill | 76.18 | 76.18 | 76.18 | 76.18 | 76.18 | 76.18 | Upgrade
|
| Other Intangible Assets | 19.9 | 24.18 | 30.36 | 36.9 | 48.08 | 79.34 | Upgrade
|
| Long-Term Deferred Tax Assets | 253.32 | 253.21 | 327.5 | 480.94 | 522.18 | 555.68 | Upgrade
|
| Other Long-Term Assets | 31.38 | 74.12 | 49.1 | 150.42 | 81.75 | 97.02 | Upgrade
|
| Total Assets | 6,343 | 6,710 | 8,527 | 9,982 | 8,199 | 6,152 | Upgrade
|
| Accounts Payable | 90.86 | 125.29 | 122.57 | 185.01 | 163.94 | 110 | Upgrade
|
| Short-Term Debt | 164.6 | 229.8 | 402.6 | 328 | 300 | 475 | Upgrade
|
| Current Portion of Long-Term Debt | 18.79 | 47.35 | 1,728 | 28.86 | 21.34 | 21.39 | Upgrade
|
| Current Portion of Leases | 21.11 | 22 | 17.32 | 13.13 | 3.32 | 3.02 | Upgrade
|
| Current Income Taxes Payable | 7.79 | 12.73 | 24.63 | 22.99 | - | - | Upgrade
|
| Current Unearned Revenue | 155.55 | 231.23 | 135 | 130.4 | 244.42 | 113.92 | Upgrade
|
| Other Current Liabilities | 235.56 | 256.82 | 349.37 | 343.94 | 331.89 | 210.47 | Upgrade
|
| Total Current Liabilities | 694.25 | 925.22 | 2,780 | 1,052 | 1,065 | 933.8 | Upgrade
|
| Long-Term Debt | 433.88 | 411.25 | 449.1 | 2,129 | 470.77 | 486.37 | Upgrade
|
| Long-Term Leases | 292.39 | 308 | 267.53 | 275.32 | 196.64 | 195.67 | Upgrade
|
| Pension & Post-Retirement Benefits | 1.25 | 3.61 | 9.16 | 10.69 | 10.83 | 11.34 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 14.06 | 14.08 | 14.15 | 14.24 | 14.35 | 18.15 | Upgrade
|
| Other Long-Term Liabilities | 10.12 | 10.28 | 10.28 | 29.53 | 15.89 | 7.62 | Upgrade
|
| Total Liabilities | 1,446 | 1,672 | 3,530 | 3,511 | 1,773 | 1,653 | Upgrade
|
| Common Stock | 1,393 | 1,393 | 1,393 | 1,394 | 1,394 | 1,390 | Upgrade
|
| Additional Paid-In Capital | 648.2 | 536.79 | 968.14 | 1,562 | 1,109 | 1,101 | Upgrade
|
| Retained Earnings | -344.66 | -352.66 | -747.51 | -727.98 | -52.82 | -631.38 | Upgrade
|
| Comprehensive Income & Other | -56.38 | 4.69 | -22.45 | -34.12 | -54.96 | -44.37 | Upgrade
|
| Total Common Equity | 1,640 | 1,582 | 1,592 | 2,194 | 2,394 | 1,815 | Upgrade
|
| Minority Interest | 3,257 | 3,456 | 3,405 | 4,277 | 4,032 | 2,684 | Upgrade
|
| Shareholders' Equity | 4,897 | 5,038 | 4,997 | 6,471 | 6,426 | 4,499 | Upgrade
|
| Total Liabilities & Equity | 6,343 | 6,710 | 8,527 | 9,982 | 8,199 | 6,152 | Upgrade
|
| Total Debt | 930.78 | 1,018 | 2,865 | 2,774 | 992.07 | 1,181 | Upgrade
|
| Net Cash (Debt) | 1,441 | 1,570 | 1,723 | 2,361 | 2,006 | 1,079 | Upgrade
|
| Net Cash Growth | -3.23% | -8.86% | -27.03% | 17.68% | 85.87% | - | Upgrade
|
| Net Cash Per Share | 10.35 | 11.27 | 12.36 | 16.97 | 14.44 | 7.77 | Upgrade
|
| Filing Date Shares Outstanding | 139.31 | 139.31 | 139.35 | 139.45 | 139.36 | 138.99 | Upgrade
|
| Total Common Shares Outstanding | 139.31 | 139.31 | 139.35 | 139.45 | 139.36 | 138.99 | Upgrade
|
| Working Capital | 2,859 | 2,736 | 2,928 | 5,681 | 3,853 | 2,088 | Upgrade
|
| Book Value Per Share | 11.77 | 11.36 | 11.42 | 15.73 | 17.18 | 13.06 | Upgrade
|
| Tangible Book Value | 1,544 | 1,482 | 1,485 | 2,081 | 2,270 | 1,660 | Upgrade
|
| Tangible Book Value Per Share | 11.08 | 10.64 | 10.66 | 14.92 | 16.29 | 11.94 | Upgrade
|
| Land | - | 330.29 | 330.29 | 354.04 | 354.04 | 354.04 | Upgrade
|
| Buildings | - | 1,468 | 1,465 | 1,506 | 1,500 | 1,495 | Upgrade
|
| Machinery | - | 1,233 | 1,266 | 1,240 | 1,178 | 1,002 | Upgrade
|
| Construction In Progress | - | 2.57 | 21.37 | 14.54 | 4.7 | 17.9 | Upgrade
|
| Leasehold Improvements | - | 9.35 | 3.34 | 3.03 | 2.55 | 1.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.